首页> 外文期刊>Journal of analytical chemistry >Determination of glimepiride in pharmaceutical formulations using HPLC and first-derivative spectrophotometric methods
【24h】

Determination of glimepiride in pharmaceutical formulations using HPLC and first-derivative spectrophotometric methods

机译:使用HPLC和一阶导数分光光度法测定药物制剂中的格列美脲

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

Two validated analytical methods have been developed to determine glimepiride in pharmaceutical formulations using HPLC and 1st order derivative spectrophotometric techniques. Employing reverse phase HPLC method, the drug was analyzed by pumping a mixture of acetonitrile and 2% formic acid solution, pH 3.5 (80: 20 v/v) through a C-18 column (250 x 4.6 mm, 5 mu m) and detecting the eluents at 228 nm. The linearity range was found to be 20-140 mu g/mL with mean recovery of 100.52 +/- 0.33%. The second method was based on the formation of a complex of the drug with 2,3,5-triphenyl-2H-tetrazolium chloride in basic media. 1st order derivative spectrum made it possible to detect the complex at 413.5 nm. The linearity range was found to be 40-160 mu g/mL, with mean recovery of 100.33 +/- 0.47%. Both the proposed methods can reliably be used for routine analysis of glimepiride in raw material as well as in pharmaceutical formulations.
机译:已开发出两种经过验证的分析方法,可使用HPLC和一阶导数分光光度法测定药物制剂中的格列美脲。采用反相HPLC方法,通过C-18色谱柱(250 x 4.6 mm,5μm)将乙腈和2%甲酸溶液(pH 3.5)(80:20 v / v)的混合物泵入,分析药物在228 nm处检测洗脱液。线性范围为20-140μg / mL,平均回收率为100.52 +/- 0.33%。第二种方法基于在碱性介质中药物与2,3,5-三苯基-2H-四唑鎓氯化物的复合物的形成。一阶导数光谱使得可以在413.5 nm处检测到络合物。线性范围为40-160μg / mL,平均回收率为100.33 +/- 0.47%。所提出的两种方法都可以可靠地用于原料药以及药物制剂中格列美脲的常规分析。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号